1 October 2025
GREGGS PLC (“Greggs” or the “Company”) Q3 TRADING UPDATE Progress in a challenging market; full year outlook unchanged Q3 highlights * Like-for-like (LFL) company-managed…
Ocean Wilsons Holdings Limited Interim results for the period ended 30 June 2025 About Ocean Wilsons Holdings Limited Ocean Wilsons Holdings Limited (“Ocean Wilsons”…
Assura plc Trading update for the first half ended 30 September 2025 Assura plc (“Assura”), the UK’s leading diversified healthcare REIT, today announces its…
30 September 2025
Watkin Jones plc (‘Watkin Jones’ or the ‘Group’) £182m PBSA Joint Venture between Watkin Jones & Maslow Capital Watkin Jones, the UK’s leading developer…
High quality portfolio performing well, Expected to exceed return target for the half year 3i Infrastructure plc (‘3iN’ or the ‘Company’) is an…
North Atlantic Smaller Companies Investment Trust plc Half-Yearly Report for the six months ended 31 July 2025 Registered in England and Wales number 1091347…
29 September 2025
AstraZeneca to harmonise its listing structure across the London Stock Exchange, Nasdaq Stockholm and New York Stock Exchange Harmonisation of listing structure requires a…
Luke Miels appointed CEO designate for GSK GSK plc (LSE/NYSE: GSK) today announces that Luke Miels is appointed CEO Designate, GSK. He will assume…